NCT03897049

Brief Summary

The study is a 2-arm cluster randomized controlled trial to be conducted with 450 trans women to assess the effectiveness of the Trans Women Connected mobile app. Those in the treatment arm will be provided with the Trans Women Connected app, to be downloaded to their own device, and asked to use it during a month period. Those in the control arm will be asked to download a general health app and use it during a month period. Participants will complete brief online surveys at baseline, immediately following the app-use period (1-month post baseline), and at 3- and 6-months following baseline. The baseline and follow-up assessments will collect data on demographic characteristics, measures related to our primary and secondary outcomes, and psychosocial measures. The primary outcome measures are self-reported sexually transmitted infection (STI)/HIV testing and sex without a condom, with secondary measures including sexual risk behaviors, health care visits, perceived social support/connectedness, pre-exposure prophylaxis (PrEP) use, self-efficacy in negotiation/communication, and comfort with gender identity and appearance. In addition, process data, such as forum content, and usage data will be collected and analyzed.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
574

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 25, 2019

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 1, 2019

Completed
2 years until next milestone

Study Start

First participant enrolled

April 1, 2021

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 7, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 7, 2022

Completed
1.7 years until next milestone

Results Posted

Study results publicly available

May 6, 2024

Completed
Last Updated

May 6, 2024

Status Verified

December 1, 2023

Enrollment Period

1.4 years

First QC Date

March 25, 2019

Results QC Date

December 8, 2023

Last Update Submit

April 5, 2024

Conditions

Keywords

Transgender WomenSTISexual HealthHIV/AIDS

Outcome Measures

Primary Outcomes (4)

  • Self-reported HIV or STI Testing in Past 3 Months

    Participant reported having tested for HIV or STI in the past 3 months

    3-months post intervention

  • Self-reported HIV or STI Testing in Past 3 Months

    Participant reported having tested for HIV or STI in the past 3 months

    6-months post intervention

  • Receptive Condomless Anal Intercourse or Condomless Vaginal Intercourse in Past 3 Months

    Participant reported having had receptive anal intercourse without a condom or receptive vaginal intercourse without a condom in the past 3 months

    3-months post intervention

  • Receptive Condomless Anal Intercourse or Condomless Vaginal Intercourse in Past 3 Months

    Participant reported having had receptive anal intercourse without a condom or receptive vaginal intercourse without a condom in the past 3 months

    6-months post intervention

Secondary Outcomes (22)

  • Use of a Condom at Last Receptive Anal Intercourse or Vaginal Intercourse

    3-month post intervention

  • Use of a Condom at Last Receptive Anal Intercourse or Vaginal Intercourse

    6-month post intervention

  • Health Care Visits in Past 3 Months

    3-months post intervention

  • Health Care Visits in Past 3 Months

    6-months post intervention

  • Mini-Medical Outcomes Study--Social Support Survey (mMOS-SS)

    1-month post intervention

  • +17 more secondary outcomes

Study Arms (2)

TWC App

EXPERIMENTAL

The intervention is a mobile app delivered sexual health promotion program designed specifically for transgender women. The mobile app includes 42 interactive activities plus resource maps, opportunities for mentoring, and communication forums for connecting with other transgender women.

Behavioral: Trans Women Connected

General Health App

ACTIVE COMPARATOR

An alternate mobile app (TWC COVID only) designed specifically for transgender women. The mobile app includes 7 interactive activities focused on COVID and COVID resources.

Behavioral: General Health App

Interventions

The intervention will address the unique needs of transgender women and the lack of evidence-based, transgender-specific HIV prevention. It is a mobile app delivered sexual health promotion program that engages transgender women through a strengths based approach to HIV prevention and sexual health that uses the power of social networks to identify and encourage protective factors that support the health of transgender women. This approach recognizes the social and structural barriers that transgender women face. In the context of these barriers, which include stigma and discrimination in a number of interconnected spheres, individually-focused behavioral interventions are insufficient. This intervention takes a more comprehensive approach that intentionally targets community strengths and challenges. The mobile app will include more than 30 interactive activities including resource maps, PrEP/PEP content, and communication forums.

TWC App

The control group will download a mobile app that addresses COVID and provides COVID resources.

General Health App

Eligibility Criteria

Age18 Years - 49 Years
Sexall(Gender-based eligibility)
Gender Eligibility DetailsAll participants must identify as transgender women.
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • aged 18-49 at the start of the study.
  • self-identify as transgender women
  • self-identify as sexually active with more than one partner in the prior 90 days
  • at least one sexual partner in the last 90 days had a penis
  • has a smartphone
  • resides in the U.S.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

ETR

Scotts Valley, California, 95066, United States

Location

Related Publications (1)

  • Ramirez-Valles J, Heckathorn DD, Vazquez R, Diaz RM, Campbell RT. From networks to populations: the development and application of respondent-driven sampling among IDUs and Latino gay men. AIDS Behav. 2005 Dec;9(4):387-402. doi: 10.1007/s10461-005-9012-3.

    PMID: 16235135BACKGROUND

MeSH Terms

Conditions

Acquired Immunodeficiency SyndromeBehaviorSexually Transmitted Diseases

Condition Hierarchy (Ancestors)

HIV InfectionsBlood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesSlow Virus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System DiseasesDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Limitations and Caveats

Relatively brief follow-up period (6 months) limits insights on longer-term impacts; some participants reported struggles with app download (affected both conditions), which may be linked to lack of more robust treatment effects; COVID impacted study progression and likely impacted behavior related to some outcomes (e.g., HIV/STI testing due to service shifts affected by COVID).

Results Point of Contact

Title
Tamara Kuhn, Vice President & Research Scientist
Organization
dfusion, Inc

Study Officials

  • Tamara Kuhn

    dfusion Inc

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Participants are randomly assigned to their condition without being made aware of their assigned condition. Each condition downloads and uses an app so study activities are similar reducing the likelihood participants will be aware of their assigned condition.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: This is a two arm randomized controlled trial. Implementation. After randomization, participants will be granted access to download and install their respective Trans Women Connected mobile apps (intervention or attention control).
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 25, 2019

First Posted

April 1, 2019

Study Start

April 1, 2021

Primary Completion

September 7, 2022

Study Completion

September 7, 2022

Last Updated

May 6, 2024

Results First Posted

May 6, 2024

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will not share

Locations